Gilead Sciences, Inc. (GILD)
Today's Latest Price: $61.56 USD
Updated Dec 4 4:00pm
Add GILD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Gilead Sciences Inc (GILD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GILD.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 25 | $105 | $58 | $73.72 | $60.86 | 21.13% |
GILD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.68 | 11 | 1 | 16 | 2 | 2 | 30 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Gilead Sciences Inc's number of analysts covering the stock is greater than 97.45% of all US stocks.
- Gilead Sciences Inc's percentage of analysts bullish on the stock is greater than 12.21% of Pharmaceutical Products stocks.
- Gilead Sciences Inc's average analyst price target is greater than 87.32% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of GILD is greater than 84.58% of stocks in the large market cap category.
- GILD has a lower percent of analysts bearish on the stock than 15.67% of Pharmaceutical Products stocks.
- GILD has a less variance in analysts' estimates than 17.39% of all US stocks.
- Gilead Sciences Inc's change in bullishness amongst analysts is lower than just about 100% of all US stocks.
Stocks similar to Gilead Sciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BIIB, GSK and GMAB.
Is GILD a Buy, Hold or Sell? See the POWR Ratings now!